Familial Cold Autoinflammatory Syndrome (FCAS)

DBCOND0034416Congenital, Hereditary, and Neonatal Diseases and Abnormalitiesimmediate and delayed hypersensitivity reactions

Familial Cold Autoinflammatory Syndrome (FCAS) is the indication for 2 drugs in DrugBank. It is covered by 2 curated, structured indications.

Also known as
Familial Cold Auto-inflammatory Syndrome · Familial Cold Urticaria · Familial Cold Autoinflammatory Syndrome · Familial Cold Autoinflam Syn (FCAS) · Familial Cold Autoinflammatory Syndromes
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0527982ICD-10M04.2SNOMED CT238687000MedDRA10064570UMLSC0343068

What you can answer from here — as of October 25, 2026

2Indicated drugsWith each drug's targets and mechanism
Listed above
2Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
8Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which approved drugs for Familial Cold Autoinflammatory Syndrome (FCAS) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In